Optimune试验方案:评估新型互联网干预对乳腺癌幸存者效果的随机对照试验
本研究为随机对照试验,计划纳入360名完成积极抗肿瘤治疗的女性乳腺癌幸存者,随机分为常规护理等待对照组与立即使用Optimune干预组,比较3个月时生活质量、体力活动和饮食质量三个主要终点,并随访至6个月。
要点
- Optimune是结合认知行为疗法与生活方式建议的互联网干预,针对乳腺癌幸存者。
- 主要终点为3个月时生活质量、体力活动和饮食质量。
- 干预组随机后立即获得12个月访问权限,对照组延迟3个月获得访问权限。
核心结论
- 该随机对照试验旨在检验Optimune互联网干预能否在3至6个月内改善乳腺癌幸存者的生活质量和相关生活方式习惯。
研究设计与样本
- 随机对照试验,计划纳入360名已完成积极抗肿瘤治疗且确诊乳腺癌不足5年的女性幸存者。
- 参与者通过德语国家网络广告和互联网论坛等渠道招募,随机分为常规护理等待对照组或立即使用Optimune干预组。
- 在线评估在基线、3个月和6个月进行。
关键数值与推荐
- 主要终点为3个月时生活质量、体力活动和饮食质量,分别采用世界卫生组织生活质量问卷、国际体力活动问卷和食品质量问卷评估。
- 次要结局包括癌因性疲乏、情绪压力、抑郁、焦虑、疾病进展恐惧、失眠、项目有用性和负面治疗效应。
- 干预组随机后立即获得12个月Optimune访问权限,对照组延迟3个月后获得访问权限。
临床怎么用
- 若证实有效,Optimune可为完成急性治疗后的乳腺癌幸存者提供可及的心理与生活方式支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Depression and fatigue are common in breast cancer survivors, and their presence is associated with personal suffering and worse prognosis. While many women receive short-term psychological support in the acute treatment phase, this is rarely available in subsequent phases. Internet interventions for breast cancer survivors could provide additional psychological support, as they are easily accessible and may be effective. However, no trial has yet examined the effectiveness of an Internet intervention that provides cognitive behavioural therapy techniques plus lifestyle advice for this population. This trial aims to test whether Optimune, a novel Internet intervention we developed for that purpose, leads to improvements in quality of life and relevant lifestyle habits over the course of 3 to 6 months. METHODS: This randomized controlled trial (RCT) will include 360 female breast cancer survivors who have completed the active tumour eradication phase. Participants will be recruited from various settings, including web-based advertisements and Internet forums in German-speaking countries. The main inclusion criteria are a breast cancer diagnosis less than 5 years ago and completion of acute treatment at least 1 month ago, as verified by discharge letter from an oncology treatment centre. Participants will be randomly assigned to either (1) a control group, in which they receive care as usual (CAU) and are given access to Optimune after a delay of 3 months (CAU/wait list control), or (2) a treatment group that may also use CAU and will receive 12-month access to Optimune immediately after randomization. The three primary endpoints are quality of life, physical activity and diet quality, assessed with the World Health Organization Quality of Life Questionnaire, the International Physical Activity Questionnaire and the Food Quality Questionnaire, at 3 months post-baseline; secondary outcomes include cancer-related fatigue, emotional stress, depression, anxiety, fear of progression, insomnia, usefulness of the programme and negative treatment effects. Online assessments are conducted at baseline (T0), 3 months (T1) and 6 months (T2). DISCUSSION: Results of this RCT are expected to extend the body of knowledge with regard to the effectiveness of CBT-based Internet interventions for female breast cancer survivors. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03643640. Registered on 23 August 2018.
引用
- Holtdirk F, Mehnert A, Weiss M, et al. Protocol for the Optimune trial: a randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors. Trials. 2020. PMID: 31996235. doi:10.1186/s13063-019-3987-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。